Matthew T. Bush

Partner at Latham & Watkins LLP

Matthew T. Bush

Matthew T. Bush

Partner at Latham & Watkins LLP

Biography

Matt Bush works with a wide variety of clients, guiding them from formation through their most important business deals, which range from venture financings to IPOs and strategic mergers and acquisitions.

Mr. Bush primarily represents life sciences and technology companies ranging from start-ups to publicly-held corporations. Mr. Bush also represents venture capital and investment banking firms in private and public financing transactions. Mr. Bush regularly advises companies in matters involving corporate governance, state and federal securities laws, fiduciary duties, employment and compensation, and SEC disclosure and reporting requirements.

A selection of Mr. Bush’s representations include:

Alphatec Spine in its acquisition of assets from Phygen and corporate governance matters
BIND Therapeutics in its initial public offering
Cadence Pharmaceuticals in its US$1.4 billion sale to Mallinckrodt plc
Conatus Pharmaceuticals in its initial public offering and in corporate governance matters
Cubic Corporation in its secondary public offering and in corporate governance matters
DJO Incorporated in its US$1.6 billion sale to an affiliate of The Blackstone Group and acquisitions of Dr. Comfort and Elastic Therapy for US$300 million
eFFECTOR Therapeutics in its venture financings with investors such as U.S. Venture Partners, Abingworth, Novartis Venture Funds, SR One and Astellas Venture Management
Elevation Pharmaceuticals in its venture financings with investors such as Canaan Partners, TPG Growth, Care Capital and Novo Ventures, and in its sale to Sunovion for proceeds of up to US$430 million
Exagen Diagnostics in proposed initial public offering and in corporate governance matters
Evoke Pharma in venture financings with investors such as Domain Associates and Latterell Venture Partners, in its initial public offering and in corporate governance matters
Level Studios in its sale to Rosetta
Mellmo in its venture financings with investors such as Sequoia Capital and in corporate governance matters
Meritage Pharma in venture financings with investors such as Domain Associates, Latterell Venture Partners and The Vertical Group, and in its exclusive, option acquisition agreement with ViroPharma Incorporated (with Shire plc as successor in interest) for up to US$240 million
Santarus in corporate governance matters, in its secondary public offering, and in its US$2.6 billion sale to Salix Pharmaceuticals
Sempra Energy in its US$510 million acquisition of EnergySouth, Inc.
weheartit.com in the initial acquisition of the image sharing online community and in its venture financings
Zogenix in its venture financings, initial public offering and follow-on offerings, and in a variety of corporate governance matters
A number of investment banks, including BofA Merrill Lynch, Citigroup, Jefferies, J.P.Morgan, Leerink, Piper Jaffray and Stifel, in public offerings of equity securities for life sciences companies, including initial public offerings for AltheaDx, Ambit Biosciences, HTG Molecular, Horizon Pharma, Insys Therapeutics, Lumena Pharmaceuticals (prior to its sale), Sophiris Bio, Tracon Pharma and Trius Therapeutics, as well as public offerings for Ardea Biosciences, Arena Pharmaceuticals, Biocryst Pharmaceuticals, Lion Biotechnologies, Mirati Therapeutics, Neurocrine Biosciences, Optimer Pharmaceuticals and Vical

Overview
RelSci Relationships

1858

Relationships
RelSci Relationships are individuals Matthew T. Bush likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chair, San Diego Emerging Companies Practice at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Cooley LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Chief Financial Officer at Cidara Therapeutics, Inc.

Relationship likelihood: Strong

Global Co-Chair, Emerging Company Practice at Latham & Watkins LLP

Relationship likelihood: Strong

Chair, Mergers & Acquisitions Practice at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Associate at Latham & Watkins LLP

Relationship likelihood: Strong

Associate at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

In The News
The Deal Pipeline
December 18, 2015
Ligand snags VC-backed antibody maker
Paths to Matthew T. Bush
Potential Connections via
Relationship Science
You
Matthew T. Bush
Partner at Latham & Watkins LLP
Education
Class of 2006

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Class of 1997

Founded in 1861 by a private gift of 10 acres in what is now the heart of downtown Seattle, the UW is one of the oldest public universities on the West Coast. We’re deeply committed to upholding the responsibility that comes with that legacy. And being public has always meant being accessible. Anyone can enjoy and be enriched by all the UW has to offer, including world-class libraries, art, music, drama, sports and the highest quality medical care in Washington state. Being public also means being engaged with our communities, and through knowledge and discovery we are elevating the quality of lives of others.

Career History
Partner
Current

Latham & Watkins LLP is a full-service law firm. The firm offers services in the areas of finance, litigation, tax, banking, life sciences, private equity, real estate, government relations, employment law, and outsourcing. The firm practices in a spectrum of transactional, litigation, corporate, and regulatory areas. Latham & Watkins was established in 1934 and is based in New York, New York.

Transactions
Details Hidden

purchases Crinetics Pharmaceuticals, Inc.

Details Hidden

Arena Pharmaceuticals, Inc. issued Common Stock

Details Hidden

Vical, Inc. issued Common Stock

Other Affiliations

Matthew T. Bush is affiliated with Latham & Watkins LLP

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthew T. Bush. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthew T. Bush's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthew T. Bush.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/matthew-t-bush-4590448
  • https://relationshipscience.com/person/matthew-t-bush-4590448